Global Adeno-Associated Virus Vector Manufacturing Market to Reach USD 3.21 Billion by 2030, Growing at a CAGR of 12.8% Summary: The global adeno-associated virus (AAV) vector manufacturing market is witnessing significant expansion, driven by advancements in gene therapy, rising demand for gene-based treatments, and increased applications across multiple industries. The market is projected to grow at a compound annual growth rate (CAGR) of 12.8%, reaching an estimated valuation of USD 3.21 billion by 2030.
Business Manager
Patton Cardenas
Espinoza Padgett
Due Greenwood
Rafferty Hurst
Merrill Jeppesen
Mckenna Coughlin
Preston Ho
Levine Weeks
Calderon Rice